U.T. MD Anderson Cancer Center, Investigational Pharmacy Services

Houston, Texas 77030

1 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Tumor, Metastatic HER2-positive Breast Cancer

Studies at this site

• A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer — Recruiting now
• A Study of NB003 in Patients With Advanced Malignancies — Completed